4//SEC Filing
FRIEDMANN NADAV 4
Accession 0001069530-22-000027
CIK 0001069530other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:20 PM ET
Size
14.3 KB
Accession
0001069530-22-000027
Insider Transaction Report
Form 4
FRIEDMANN NADAV
DirectorChief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-27$23.38/sh−3,501$81,853→ 0 totalExercise: $23.38From: 2016-06-08Exp: 2022-06-08→ Common Stock (3,501 underlying) - Tax Payment
Common Stock
2022-05-27$26.66/sh−3,071$81,873→ 92,032 total - Exercise/Conversion
Common Stock
2022-05-27$23.38/sh+3,501$81,853→ 70,590 total - Exercise/Conversion
Common Stock
2022-05-27$23.38/sh+24,513$573,114→ 95,103 total - Tax Payment
Common Stock
2022-05-27$26.66/sh−21,498$573,137→ 70,534 total - Exercise/Conversion
Common Stock
2022-05-27$23.38/sh−24,513$573,114→ 0 totalExercise: $23.38From: 2016-06-08Exp: 2022-06-08→ Common Stock (24,513 underlying)
Holdings
- 143(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.
Documents
Issuer
CASSAVA SCIENCES INC
CIK 0001069530
Entity typeother
Related Parties
1- filerCIK 0001245267
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:20 PM ET
- Size
- 14.3 KB